Dr. Mamounas on Future of Surgical Treatments in Breast Cancer

Eleftherios P. Mamounas, MD
Published: Tuesday, Jan 05, 2016



Eleftherios P. Mamounas, MD, surgical oncologist, UF Health Cancer Center - Orlando Health, shares the future of surgical treatments for patients with breast cancer.

Individualization will play a major role in determining surgical options for patients with breast cancer, Mamounas says. For younger patients who are candidates for endocrine therapy versus mastectomy, the risk of recurrence is up to 25%, leading some women to opt for mastectomies. However, older patients are less likely to undergo mastectomies as they have less of a benefit, Mamounas explains.

For women with HR-positive disease, however, the risk of breast cancer recurrence is significantly reduced by approximately 50%. These statistics are important for oncologists to discuss with patients, so they are informed on all of their treatment options.



Eleftherios P. Mamounas, MD, surgical oncologist, UF Health Cancer Center - Orlando Health, shares the future of surgical treatments for patients with breast cancer.

Individualization will play a major role in determining surgical options for patients with breast cancer, Mamounas says. For younger patients who are candidates for endocrine therapy versus mastectomy, the risk of recurrence is up to 25%, leading some women to opt for mastectomies. However, older patients are less likely to undergo mastectomies as they have less of a benefit, Mamounas explains.

For women with HR-positive disease, however, the risk of breast cancer recurrence is significantly reduced by approximately 50%. These statistics are important for oncologists to discuss with patients, so they are informed on all of their treatment options.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: Medical Crossfire®: Translating Lessons Learned with PARP Inhibition to the Treatment of Breast Cancer—Expert Exchanges on Novel Strategies to Personalize CareAug 29, 20181.5
Publication Bottom Border
Border Publication
x